The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis

BACKGROUND: Benefit of thrombolytic therapy in patients with massive pulmonary embolism (PE) is evident. However, evidence supporting benefit in clinical outcomes of this approach in intermediate risk PE is lacking. OBJECTIVE: To determine the impact of thrombolysis on overall survival in intermedia...

Descripción completa

Detalles Bibliográficos
Autores principales: Alcedo, Pedro E., García‐Perdomo, Herney Andrés, Rojas‐Hernandez, Cristhiam M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Sickle Cell, Thrombosis, and Haematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176023/
https://www.ncbi.nlm.nih.gov/pubmed/35844995
http://dx.doi.org/10.1002/jha2.97

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176023/
https://www.ncbi.nlm.nih.gov/pubmed/35844995
http://dx.doi.org/10.1002/jha2.97

Ejemplares similares